Drugs Made In America Acquisition Corp
DMAA10.440USD
-0.010-0.10%
終値 02/06, 16:00（ET）15分遅れの株価
349.92M時価総額
95.17直近12ヶ月PER
詳細情報 Drugs Made In America Acquisition Corp 企業名
Drugs Made In America Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses. The Company intends to focus its search for businesses in the pharmaceutical industry. The Company has neither engaged in any operations nor generated any revenues.
Drugs Made In America Acquisition Corpの企業情報
企業コードDMAA
会社名Drugs Made In America Acquisition Corp
上場日Jan 28, 2025
最高経営責任者「CEO」Stockwell (Lynn)
従業員数- -
証券種類Ordinary Share
決算期末Jan 28
本社所在地1 East Broward Boulevard
都市FT LAUDERDALE
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号33301
電話番号19548703099
ウェブサイト
企業コードDMAA
上場日Jan 28, 2025
最高経営責任者「CEO」Stockwell (Lynn)
Drugs Made In America Acquisition Corpの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Catherine Do
Dr. Catherine Do
Independent Director Nominee
Independent Director Nominee
100.00K
--
Ms. Lynn Stockwell
Ms. Lynn Stockwell
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
--
--
Dr. G. Sridhar Prasad
Dr. G. Sridhar Prasad
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Myron W. Shulgan
Mr. Myron W. Shulgan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Saleem Elmasri, CPA
Mr. Saleem Elmasri, CPA
Chief Financial Officer, Principal Financial and Accounting Officer
Chief Financial Officer, Principal Financial and Accounting Officer
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
他の
49.03%
株主統計
株主統計
比率
Drugs Made In America Acquisition LLC
25.57%
Karpus Investment Management
7.60%
First Trust Capital Management L.P.
6.69%
Polar Asset Management Partners Inc.
5.67%
Glazer Capital, LLC
5.44%
他の
49.03%
種類
株主統計
比率
Hedge Fund
30.42%
Corporation
25.57%
Investment Advisor/Hedge Fund
24.61%
Investment Advisor
5.80%
Research Firm
5.62%
Individual Investor
1.19%
他の
6.79%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
47
22.21M
67.76%
-8.45K
2025Q3
47
22.22M
67.76%
+1.02M
2025Q2
38
21.21M
54.90%
+2.81M
2025Q1
25
18.33M
0.00%
+18.33M
2024Q4
5
4.59M
15.73%
+4.59M
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Drugs Made In America Acquisition LLC
8.57M
25.57%
+4.38M
+104.63%
Feb 25, 2025
Karpus Investment Management
2.55M
7.6%
-196.44K
-7.16%
Sep 30, 2025
First Trust Capital Management L.P.
2.24M
6.69%
--
--
Sep 30, 2025
Polar Asset Management Partners Inc.
1.90M
5.67%
--
--
Sep 30, 2025
Glazer Capital, LLC
1.82M
5.44%
-158.00
-0.01%
Sep 30, 2025
Westchester Capital Management, LLC
1.67M
4.98%
--
--
Sep 30, 2025
Hudson Bay Capital Management LP
1.55M
4.62%
-250.00K
-13.89%
Sep 30, 2025
Wolverine Asset Management, LLC
1.25M
3.73%
+227.22K
+22.24%
Sep 30, 2025
Mizuho Securities USA, LLC.
1.10M
3.28%
+180.66K
+19.64%
Sep 30, 2025
Aristeia Capital, L.L.C.
881.72K
2.63%
--
--
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
CrossingBridge Pre-Merger SPAC ETF
0%
CrossingBridge Pre-Merger SPAC ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
